| Year |
Citation |
Score |
| 2023 |
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, et al. MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study. Focus (American Psychiatric Publishing). 21: 315-328. PMID 37404971 DOI: 10.1176/appi.focus.23021011 |
0.541 |
|
| 2021 |
Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nature Medicine. PMID 33972795 DOI: 10.1038/s41591-021-01336-3 |
0.542 |
|
| 2020 |
Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J. Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study. Eclinicalmedicine. 27: 100538. PMID 33150319 DOI: 10.1016/j.eclinm.2020.100538 |
0.502 |
|
| 2020 |
Coker AR, Weinstein DN, Vega TA, Miller CS, Kayser AS, Mitchell JM. The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder. Psychopharmacology. PMID 32617646 DOI: 10.1007/s00213-020-05599-5 |
0.606 |
|
| 2020 |
Flanagan JC, Mitchell JM, Baker NL, Woolley J, Wangelin B, Back SE, McQuaid JR, Neylan TC, Woolfe WR, Brady KT. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemporary Clinical Trials. 106074. PMID 32561468 DOI: 10.1016/J.Cct.2020.106074 |
0.564 |
|
| 2019 |
Anderson B, Danforth A, Daroff R, Stauffer C, Dilley J, Mitchell J, Woolley J. T137. Psilocybin-Assisted Group Therapy for Demoralization in Long-Term AIDS Survivors Biological Psychiatry. 85. DOI: 10.1016/J.Biopsych.2019.03.460 |
0.529 |
|
| 2017 |
Kayser AS, Vega T, Weinstein D, Peters J, Mitchell JM. Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers. Neuroimage. Clinical. 13: 339-348. PMID 28066708 DOI: 10.1016/J.Nicl.2016.12.022 |
0.307 |
|
| 2016 |
Mitchell JM, Arcuni PA, Weinstein D, Woolley JD. Intranasal Oxytocin Selectively Modulates Social Perception, Craving, and Approach Behavior in Subjects With Alcohol Use Disorder. Journal of Addiction Medicine. PMID 27159342 DOI: 10.1097/ADM.0000000000000213 |
0.608 |
|
| 2015 |
Mitchell J, Weinstein D, Arcuni P, Laxamana J, Woolley J. The effects of intranasal oxytocin on social cognition, implicit preferences and craving in alcoholics Drug and Alcohol Dependence. 146: e42. DOI: 10.1016/J.DRUGALCDEP.2014.09.485 |
0.585 |
|
| 2014 |
Mitchell JM, Margolis EB, Coker AR, Allen DC, Fields HL. Intra-VTA deltorphin, but not DPDPE, induces place preference in ethanol-drinking rats: distinct DOR-1 and DOR-2 mechanisms control ethanol consumption and reward. Alcoholism, Clinical and Experimental Research. 38: 195-203. PMID 24033469 DOI: 10.1111/Acer.12246 |
0.768 |
|
| 2013 |
Mitchell JM, O'Neil JP, Jagust WJ, Fields HL. Catechol-O-methyltransferase genotype modulates opioid release in decision circuitry. Clinical and Translational Science. 6: 400-3. PMID 24127930 DOI: 10.1111/cts.12075 |
0.611 |
|
| 2012 |
Kayser AS, Allen DC, Navarro-Cebrian A, Mitchell JM, Fields HL. Dopamine, corticostriatal connectivity, and intertemporal choice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 32: 9402-9. PMID 22764248 DOI: 10.1523/Jneurosci.1180-12.2012 |
0.533 |
|
| 2012 |
Mitchell JM, Margolis EB, Coker AR, Fields HL. Alcohol self-administration, anxiety, and cortisol levels predict changes in delta opioid receptor function in the ventral tegmental area. Behavioral Neuroscience. 126: 515-22. PMID 22708955 DOI: 10.1037/a0029027 |
0.782 |
|
| 2012 |
Mitchell JM, Teague CH, Kayser AS, Bartlett SE, Fields HL. Varenicline decreases alcohol consumption in heavy-drinking smokers. Psychopharmacology. 223: 299-306. PMID 22547331 DOI: 10.1007/S00213-012-2717-X |
0.534 |
|
| 2012 |
Mitchell JM, Grossman LE, Coker AR, Messing RO. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers. Journal of Clinical Psychopharmacology. 32: 269-72. PMID 22367657 DOI: 10.1097/JCP.0b013e318248ba69 |
0.608 |
|
| 2012 |
Mitchell JM, O'Neil JP, Janabi M, Marks SM, Jagust WJ, Fields HL. Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens. Science Translational Medicine. 4: 116ra6. PMID 22238334 DOI: 10.1126/scitranslmed.3002902 |
0.632 |
|
| 2012 |
Kayser A, Allen D, Navarro-Cebrian A, Mitchell J, Fields H. Impulsivity and Catechol-O-Methyltransferase Inhibition: A Translational Study (SC01.001) Neurology. 78: SC01.001-SC01.001. DOI: 10.1212/Wnl.78.1_Meetingabstracts.Sc01.001 |
0.457 |
|
| 2011 |
Margolis EB, Mitchell JM, Hjelmstad GO, Fields HL. A novel opioid receptor-mediated enhancement of GABAA receptor function induced by stress in ventral tegmental area neurons. The Journal of Physiology. 589: 4229-42. PMID 21690191 DOI: 10.1113/jphysiol.2011.209023 |
0.747 |
|
| 2009 |
Boettiger CA, Kelley EA, Mitchell JM, D'Esposito M, Fields HL. Now or Later? An fMRI study of the effects of endogenous opioid blockade on a decision-making network. Pharmacology, Biochemistry, and Behavior. 93: 291-9. PMID 19258022 DOI: 10.1016/j.pbb.2009.02.008 |
0.552 |
|
| 2009 |
Mitchell JM, Bergren LJ, Chen KS, Rowbotham MC, Fields HL. Naltrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol. Neurobiology of Disease. 33: 72-80. PMID 18955144 DOI: 10.1016/j.nbd.2008.09.018 |
0.603 |
|
| 2008 |
Margolis EB, Fields HL, Hjelmstad GO, Mitchell JM. Delta-opioid receptor expression in the ventral tegmental area protects against elevated alcohol consumption. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 12672-81. PMID 19036960 DOI: 10.1523/JNEUROSCI.4569-08.2008 |
0.772 |
|
| 2008 |
Margolis EB, Mitchell JM, Ishikawa J, Hjelmstad GO, Fields HL. Midbrain dopamine neurons: projection target determines action potential duration and dopamine D(2) receptor inhibition. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 8908-13. PMID 18768684 DOI: 10.1523/JNEUROSCI.1526-08.2008 |
0.733 |
|
| 2007 |
Boettiger CA, Mitchell JM, Tavares VC, Robertson M, Joslyn G, D'Esposito M, Fields HL. Immediate reward bias in humans: fronto-parietal networks and a role for the catechol-O-methyltransferase 158(Val/Val) genotype. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14383-91. PMID 18160646 DOI: 10.1523/JNEUROSCI.2551-07.2007 |
0.547 |
|
| 2007 |
Mitchell JM, Fields HL, White RL, Meadoff TM, Joslyn G, Rowbotham MC. The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers. Journal of Clinical Psychopharmacology. 27: 112-5. PMID 17224736 DOI: 10.1097/JCP.0b013e31802e68b0 |
0.603 |
|
| 2007 |
Mitchell JM, Tavares VC, Fields HL, D'Esposito M, Boettiger CA. Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 32: 439-49. PMID 17047667 DOI: 10.1038/sj.npp.1301226 |
0.608 |
|
| 2006 |
Mitchell JM, Bergren LJ, Chen KS, Fields HL. Cholecystokinin is necessary for the expression of morphine conditioned place preference. Pharmacology, Biochemistry, and Behavior. 85: 787-95. PMID 17196636 DOI: 10.1016/j.pbb.2006.11.014 |
0.574 |
|
| 2005 |
Mitchell JM, Fields HL, D'Esposito M, Boettiger CA. Impulsive responding in alcoholics. Alcoholism, Clinical and Experimental Research. 29: 2158-69. PMID 16385186 DOI: 10.1097/01.alc.0000191755.63639.4a |
0.539 |
|
| 2005 |
Mitchell JM, Liang MT, Fields HL. A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology. 182: 384-92. PMID 16001119 DOI: 10.1007/s00213-005-0067-7 |
0.605 |
|
| 2004 |
Paladini CA, Mitchell JM, Williams JT, Mark GP. Cocaine self-administration selectively decreases noradrenergic regulation of metabotropic glutamate receptor-mediated inhibition in dopamine neurons. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 5209-15. PMID 15175391 DOI: 10.1523/Jneurosci.1079-04.2004 |
0.664 |
|
| 2004 |
Valverde O, Mantamadiotis T, Torrecilla M, Ugedo L, Pineda J, Bleckmann S, Gass P, Kretz O, Mitchell JM, Schütz G, Maldonado R. Modulation of anxiety-like behavior and morphine dependence in CREB-deficient mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 1122-33. PMID 15029152 DOI: 10.1038/sj.npp.1300416 |
0.345 |
|
| 2000 |
Tershner SA, Mitchell JM, Fields HL. Brainstem pain modulating circuitry is sexually dimorphic with respect to mu and kappa opioid receptor function. Pain. 85: 153-9. PMID 10692614 DOI: 10.1016/S0304-3959(99)00257-2 |
0.755 |
|
| 2000 |
Mitchell JM, Basbaum AI, Fields HL. A locus and mechanism of action for associative morphine tolerance. Nature Neuroscience. 3: 47-53. PMID 10607394 DOI: 10.1038/71120 |
0.648 |
|
| 1998 |
Mitchell JM, Lowe D, Fields HL. The contribution of the rostral ventromedial medulla to the antinociceptive effects of systemic morphine in restrained and unrestrained rats. Neuroscience. 87: 123-33. PMID 9722146 DOI: 10.1016/S0306-4522(98)00119-5 |
0.505 |
|
| Show low-probability matches. |